Valuation: Danaher Corporation

Capitalization 16TCr 14TCr 13TCr 12TCr 22TCr 14,47500Cr 24TCr 1,48000Cr 57TCr 6,82500Cr 60TCr 59TCr 24,90200Cr P/E ratio 2025 *
43.5x
P/E ratio 2026 * 32.8x
Enterprise value 17TCr 15TCr 14TCr 13TCr 24TCr 15,68500Cr 26TCr 1,60400Cr 62TCr 7,39500Cr 65TCr 64TCr 26,98400Cr EV / Sales 2025 *
7.07x
EV / Sales 2026 * 6.66x
Free-Float
72.69%
Yield 2025 *
0.55%
Yield 2026 * 0.6%
More valuation ratios * Estimated data
Dynamic Chart
1 day-2.60%
1 week+0.04%
Current month-0.20%
1 month+2.32%
3 months+19.09%
6 months+12.79%
Current year-1.40%
More quotes
1 week 223.19
Extreme 223.19
232.82
1 month 217.86
Extreme 217.862
232.82
Current year 171
Extreme 171
258.23
1 year 171
Extreme 171
258.23
3 years 171
Extreme 171
281.7
5 years 171
Extreme 171
333.96
10 years 75.71
Extreme 75.71
333.96
More quotes
Manager TitleAgeSince
Chief Executive Officer 61 01/09/2020
Director of Finance/CFO 53 01/01/2019
Chief Tech/Sci/R&D Officer - 25/08/2025
Director TitleAgeSince
Director/Board Member 73 01/07/1999
Chairman 73 01/01/1983
Director/Board Member 68 01/01/1983
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-2.60%+0.04%-3.64%-18.20% 16TCr
-1.14%-0.09%+8.61%+0.16% 22TCr
-0.92%-5.74%+0.51%+92.49% 19TCr
+0.90%-5.07%+2.74%+96.14% 14TCr
+0.98%+1.20%-17.70%-13.63% 5.77TCr
-1.38%-3.61%+13.31%+9.37% 4.82TCr
-2.23%-3.99%+0.49%-11.40% 3.95TCr
-2.43%-1.76%+3.53% - 3.82TCr
-0.05%-1.67%+5.76%+12.77% 3.68TCr
+2.07%-1.27%-22.90%-36.04% 3.43TCr
Average -0.68%-2.04%-0.93%+14.63% 9.59TCr
Weighted average by Cap. -0.87%-2.28%+0.99%+28.83%
See all sector performances

Financials

2025 *2026 *
Net sales 2.45TCr 2.09TCr 1.95TCr 1.83TCr 3.37TCr 2,21900Cr 3.69TCr 23TCr 8.81TCr 1,04600Cr 9.2TCr 9TCr 3,81800Cr 2.55TCr 2.17TCr 2.03TCr 1.91TCr 3.51TCr 2,30900Cr 3.84TCr 24TCr 9.17TCr 1,08900Cr 9.57TCr 9.36TCr 3,97200Cr
Net income 366.93Cr 312.65Cr 291.8Cr 274.45Cr 504.93Cr 33TCr 552.91Cr 3.4TCr 1.32TCr 16TCr 1.38TCr 1.35TCr 57TCr 495.95Cr 422.58Cr 394.41Cr 370.95Cr 682.47Cr 45TCr 747.33Cr 4.59TCr 1.78TCr 21TCr 1.86TCr 1.82TCr 77TCr
Net Debt 1.34TCr 1.14TCr 1.06TCr 999.77Cr 1.84TCr 1,21000Cr 2.01TCr 12TCr 4.81TCr 57TCr 5.02TCr 4.91TCr 2,08200Cr 1TCr 854.48Cr 797.51Cr 750.08Cr 1.38TCr 91TCr 1.51TCr 9.28TCr 3.61TCr 43TCr 3.76TCr 3.68TCr 1,56200Cr
More financial data * Estimated data
Logo Danaher Corporation
Danaher Corporation is an industrial and technologic group organized around three families of products: - diagnostic equipment (41% of net sales); - life sciences equipment (30.7%); - biotechnology equipment (28.3%): ranging from basic biological research to the development and manufacturing of vaccines, biological drugs, cell and gene therapies, and new technologies such as mRNA. Net sales are distributed geographically as follows: the United States (41.6%), China (11.7%) and other (46.7%).
Employees
62,000
More about the company
Date Price Change Volume
12/25/12 226.33 $ -2.60% 48,58,304
11/25/11 232.37 $ +0.85% 57,81,865
10/25/10 230.42 $ +3.22% 39,13,981
09/25/09 223.23 $ -0.56% 33,69,194
08/25/08 224.48 $ -0.78% 29,45,934

Delayed Quote Nyse, December 13, 2025 at 02:30 am IST

More quotes
Trader
Investor
Global
Quality
ESG MSCI
AA
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
226.33USD
Average target price
256.09USD
Spread / Average Target
+13.15%
Consensus

Quarterly revenue - Rate of surprise